Xella Health Integrates Oura Data into Women's Care - oura women's health
By combining wearable data with multiomic insights, Xella aims to address symptoms effectively while proactively improving health trajectories over decades.

Women’s health platform Xella Health has integrated wearable data from Oura into its diagnostic and care services, enabling members to share biometric information with clinicians alongside test results. The partnership combines Xella’s AI-driven multiomic testing with physician-guided telehealth to support personalized care plans. Members can opt to share Oura insights such as sleep patterns, heart rate variability, resting heart rate, temperature trends, recovery metrics, activity levels, and menstrual cycle data.

Integration of Wearable and Diagnostic Data

Xella’s multiomic testing evaluates hormonal and metabolic health, inflammation, nutritional status, reproductive health, and cardiometabolic risk. Physicians use these findings to develop individualized care plans that may include clinical treatments. Clinicians can review shared Oura trends alongside diagnostic results and member check-ins to monitor progress and adjust care over time, interpreting biometric data within each member’s specific health conditions, goals, and treatment plans.

“Wearables detect that something in the body has changed, but wearable data alone can’t tell a woman why or what to do next with that information,” said Kelly Lacob, CEO and cofounder of Xella Health, in a statement. She added that pairing continuous physiological monitoring from Oura with Xella’s multiomic diagnostics and physician-guided care allows women to understand how health concerns impact biometrics, and how daily habits affect specific conditions or life stages. The integration aims to track how vitals and biometrics respond to interventions, optimizing care more efficiently.

Focus on Key Women’s Health Areas

The integration targets fertility, perimenopause, cardiometabolic, and hormonal health, as well as long-term women’s health outcomes. By combining wearable data with multiomic insights, Xella aims to address symptoms effectively while proactively improving health trajectories over decades. The company emphasized that providers will contextualize biometric data to each member’s unique health journey.

Oura’s Expanding Women’s Health Offerings

Oura has been actively expanding its women’s health capabilities. In February, the company partnered with at-home hormone tracking firm Mira to let users view hormone test results alongside sleep, temperature, and readiness data in the Mira app, aiding pattern tracking for fertility and menstrual cycles. That same month, Oura introduced a women’s health AI model through Oura Labs, integrated into Oura Advisor, combining biometric data with clinician-reviewed medical information for guidance on menstrual cycles, pregnancy, and menopause. In May, Oura launched Menopause Insights, a questionnaire covering 22 menopause symptoms paired with wearable data, and birth control support to help users interpret biometric trends in the context of hormonal contraception.